Cordlife Group Limited operates in the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cordlife Group Limited with three other
health care providers in Asia:
Green Cross Lab Cell Corp
of KOREA (SOUTH)
sales of 57.90 billion Korean Won [US$50.77 million]
of which 75%
was Clinical Laboratory Services),
(18.99 million Singapore Dollars [US$13.98 million]
Human Health Holdings Ltd
based in HONG KONG
(528.59 million Hong Kong Dollars [US$68.20 million]
of which 64%
was General practice services).
Cordlife Group Limited reported sales of 61.58 million Singapore Dollars (US$45.35 million)
December of 2019.
decrease of 12.0%
versus 2018, when the company's sales were 70.00 million Singapore Dollars.
Contributing to the drop in overall sales was the 13.1% decline
in Banking, from 69.05 million Singapore Dollars to 60.01 million Singapore Dollars.
However, these declines were partially offset by the increase in sales of
Diagnostics (up 64.3% to 1.57 million Singapore Dollars)